Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 132 for

Edit search filters
  1. Myocardial Infarction Genes (MI-GENES) Study

    Rochester, MN

  2. Cardiovascular Health Promotion Among African-Americans by FAITH!

    Rochester, MN

  3. AI-ECG Algorithms to Identify Cardiac Disease in Youth Athletes

    Rochester, MN

  4. Safety And Efficacy Of ANX-042 In Human Cardiorenal Syndrome

    Rochester, MN

  5. A Study Of The Effect Of Dapagliflozin On Symptoms And Biomarkers In Diabetes Patients With Heart Failure

    Rochester, MN

  6. Vascular Function and Uterine Fibroids

    Rochester, MN

  7. Clinical Evaluation of the CADence Device in Detection of Coronary Artery Diseases

    Rochester, MN

  8. Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III

    Rochester, MN, Rochester, MN

  9. Physiologic Effects of Sleep Restriction

    Rochester, MN

  10. Evaluation Of Major Cardiovascular Events In Patients With, Or At High Risk For, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) Or Placebo

    La Crosse, WI

.

Mayo Clinic Footer